GSK3B and colorectal carcinoma: Research by Zhang et al. showed that the glycogen synthase kinase 3 beta (GSK3β)/FTO/myeloid zinc finger 1 (MZF1)/c-MYC axis suppressed the development of colorectal carcinoma (CRC) [26].